GSK 260116 40.00C (GSK260116C40000) Stock Options, News & Quotes

US OptionsDetailed Quotes

GSK260116C40000

Watchlist

1.41
+0.21+17.50%

15min DelayClose Nov 22 16:00 ET

1.45High1.25Low

Intraday

5D
Daily

News

Blenrep Combinations Accepted for Review by the US FDA for the Treatment of Relapsed/refractory Multiple Myeloma
GSK Plc00:00 ET
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Seeking AlphaNov 22 21:25 ET
GSK's RSV Vaccine Approved for Japanese Patients in Their 50s
MT NewswiresNov 22 07:05 ET
Arexvy Approval Expanded to Adults Aged 50-59 at Increased Risk of Severe RSV Disease in Japan
GSK PlcNov 22 00:00 ET
Optimism Over Global Healthcare Sector Rises: Jefferies
Seeking AlphaNov 21 13:45 ET
Vicebio Advances Clinical Study of RSV/hMPV Bivalent Vaccine & Strengthens Board With Appointments of World Class Veterans
PR NewswireNov 21 03:30 ET

Comments

corbotron

Oct 10 09:25

I hope these bullies get decimated

$Pfizer (PFE.US)$ destroyed the shareholder confidence again. company isn't interested in shareholder value. latest threat of legal action against the former executives shows the company has no intention of curbing their careless cash spend. it's gone from creating value for shareholders to taking value from shareholders. bullies thinking they can do what they want with no repercussions. I hope their share price gets decimated over their poor decision to use forc...

Moomoo Breakfast US

Oct 10 06:53

Columns US Morning News Call | U.S. Stock Futures Drop Ahead of Key Inflation Report; Tesla Robotaxi Event Catches Attention

Expand

Tesla's "Cybercab" global debut sends stock falling

corbotron

Oct 9 15:33

$Pfizer (PFE.US)$ another positive, keep an eye $GlaxoSmithKline (GSK.US)$ $Apple (AAPL.US)$ $

Pfizer Inc - Declares $0.42 Fourth-Quarter 2024 Dividend

corbotron

Oct 9 15:07

$Pfizer (PFE.US)$ definitely an opportunity here to catch the rise, CEO will be meeting next week with new investor. discussions on directions will most likely be on the table and trimming the fat of recent acquisitions. speculation is making this stock rise until the news from the meeting is released. it's looking like there is more in the rumor mill and the price is reflecting it over the last couple sessions. keep an eye $Apple (AAPL.US)$ $Novo-Nordisk A/S (NVO.US)$ $GlaxoSmithKline (GSK.US)$

corbotron

Oct 9 12:29

$Pfizer (PFE.US)$ could see 32$ before the end of tomorrow , keep an eye $GlaxoSmithKline (GSK.US)$ $Summit Therapeutics (SMMT.US)$ $Ascendis Pharma A/S (ASND.US)$